Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyell Immunopharma (LYEL) Cash from Investing Activities (2020 - 2025)

Lyell Immunopharma (LYEL) has disclosed Cash from Investing Activities for 6 consecutive years, with -$31.4 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 158.62% to -$31.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.1 million through Dec 2025, down 55.81% year-over-year, with the annual reading at $54.1 million for FY2025, 55.81% down from the prior year.
  • Cash from Investing Activities hit -$31.4 million in Q4 2025 for Lyell Immunopharma, down from $3.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $152.9 million in Q2 2023 to a low of -$144.9 million in Q3 2021.
  • Historically, Cash from Investing Activities has averaged $11.4 million across 5 years, with a median of $17.3 million in 2024.
  • Biggest five-year swings in Cash from Investing Activities: crashed 328.06% in 2021 and later surged 511.18% in 2023.
  • Year by year, Cash from Investing Activities stood at -$73.9 million in 2021, then surged by 163.16% to $46.6 million in 2022, then plummeted by 315.85% to -$100.7 million in 2023, then soared by 153.14% to $53.5 million in 2024, then crashed by 158.62% to -$31.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for LYEL at -$31.4 million in Q4 2025, $3.3 million in Q3 2025, and $12.6 million in Q2 2025.